Cardiff, UK -- 27 September 2011 - Kay Swinburne, MEP visited GE Healthcare's Maynard Centre in Cardiff, Wales on Friday 23rd September. The Maynard Centre, operational since 1980 and with approximately 450 employees, is a key research and manufacturing facility for GE Healthcare's Life Sciences business.
Bangalore, India -- September 20, 2011 -- GE India announced today the appointment of Ms. Terri Bresenham to lead GE's healthcare's business in India. Bresenham will continue to develop and strengthen the 'In India, for India' focus nurtured by GE. She replaces Mr. V Raja, who has been leading GE Healthcare's business since 2002
business unit
tags
Standards-based eHealth Platform Now Offered to Public and Private Sector in Australia
MELBOURNE, Australia; 20 September, 2011: GE Healthcare is launching its proven, standards-based eHealth platform, eHealth Information Exchange, at the Healthcare Information and Management Systems Society (HIMSS) AsiaPAC 11 Conference and Health IT Leadership Summit being held from 20-22 September, 2011 in Melbourne.
business unit
tags
New ultrasound technologies bring amazing realism to ultrasound imaging
Los Angeles, CA. Monday September 19, 2011 -- GE Healthcare has announced today the availability of HDlive and Volume SRI (Speckle Reduction Imaging) for women's health imaging products within its Voluson Expert series platform. These innovations are being showcased for the first time in the United States at the 2011 International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) congress in Los Angeles.
business unit
tags
* Agreement covers intellectual property relating to biopharmaceutical manufacturing technologies
Aubagne, France; Goettingen, Germany and Chalfont St. Giles, UK - September 12, 2011 -- Sartorius Stedim Biotech has entered into a patent cross-licensing agreement with GE Healthcare Life Sciences. This will enable the further development of each company's current and future biopharmaceutical manufacturing technologies.
business unit
tags
Adopted by more than 100 leading clinicians worldwide, Alcyone technology has become an accepted technology for nuclear cardiology diagnosis
Harnessing four advanced nuclear imaging innovations, Alcyone technology has the ability to reduce scan time and/or injected dose while maintaining image quality †